Results 221 to 230 of about 260,584 (356)
Strength through diversity: how cancers thrive when clones cooperate
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken +3 more
wiley +1 more source
Steric Pruning Unlocks Hierarchical Structuring, Thermochromism, C-H/O Activation, and 6-electron Redox Transmetalation in Planar Bismuth Triamides. [PDF]
Howlett WP +5 more
europepmc +1 more source
Implicit bias, confabulation, and epistemic innocence
Ema Sullivan‐Bissett
openalex +1 more source
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto +8 more
wiley +1 more source
Prohibited Olympic Medalist with PIEZO1 VUS Who Claims Innocence. [PDF]
Sonkodi B +8 more
europepmc +1 more source
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice +16 more
wiley +1 more source
Does the Forensic Filler-Control Method Reduce Examiner Overconfidence? An Experimental Investigation Using Mock Fingerprint Examiners. [PDF]
Rath HJ, Rocha B, Smith AM, Smalarz L.
europepmc +1 more source
Potential therapeutic targeting of BKCa channels in glioblastoma treatment
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak +4 more
wiley +1 more source

